Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.
暂无分享,去创建一个
E N Atkinson | N. Sneige | S. Lippman | M. Lagios | A. Sahin | M. Follen | C. Boone | G. Kelloff | W. Colburn | E. Atkinson | I. Boiko | K. Dhingra | W. Hittelman | W N Hittelman | S M Lippman | A Hoque | I V Boiko | N Sneige | A Sahin | D M Weber | S Risin | M D Lagios | R Schwarting | W J Colburn | K Dhingra | M Follen | G J Kelloff | C W Boone | R. Schwarting | A. Hoque | S. Risin | D. Weber | D. Weber | G. Kelloff | Seymon A Risin
[1] F. B. Sørensen,et al. Reproducibility of mean nuclear volume and correlation with mean nuclear area in breast cancer: an investigation of various sampling schemes. , 1994, Human pathology.
[2] G. Serio,et al. Nuclear shape and axillary metastases in breast cancer. Analytic morphometry of aspiration smears. , 1994, Acta cytologica.
[3] L. Liberman,et al. Long term follow‐up of women with ductal carcinoma in situ treated with breast‐conserving surgery , 1999, Cancer.
[4] R. Mansel,et al. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma , 1996, Histopathology.
[5] A W Partin,et al. A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. , 1989, The Journal of urology.
[6] B Fisher,et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.
[7] Geoff Delaney M.B.B.S.,et al. Predictors of local recurrence after treatment of ductal carcinoma in situ - A meta-analysis , 1999 .
[8] J. Torhorst,et al. Prognostic significance (relapse, non-relapse) of nuclear shape parameters in lymph node negative breast cancer. , 1989, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.
[9] G. Hortobagyi,et al. Ductal Carcinoma-In-Situ: Long-Term Results of Breast-Conserving Therapy , 2000, Annals of Surgical Oncology.
[10] N. Sneige,et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. , 1995, Human pathology.
[11] G. Schwartz,et al. Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. , 2000, Cancer.
[12] P. O’Connell,et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. , 1998, Journal of the National Cancer Institute.
[13] J. Costantino,et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Stanford,et al. Risk of recurrence after ductal carcinoma in situ of the breast. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[15] J. Boyages,et al. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. , 1999, Cancer.
[16] Z. Werb,et al. Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial Cells , 1997, The Journal of cell biology.
[17] David A. Belsley,et al. Conditioning Diagnostics: Collinearity and Weak Data in Regression , 1991 .
[18] M. Lagios. Duct carcinoma in situ. Pathology and treatment. , 1990, The Surgical clinics of North America.
[19] Joseph Costantino,et al. Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17. Intraductal carcinoma (ductal carcinoma in situ) , 1995, Cancer.
[20] S. Martino,et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.
[21] J. Hendriks,et al. Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ , 1990, The Lancet.
[22] S. Paik,et al. Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS) , 1986, Cancer.
[23] R. Baker,et al. Prognostic factors in patients with stage I, estrogen receptor‐negative carcinoma of the breast. A clinicopathologic study , 1983, Cancer.
[24] G. Schwartz,et al. [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999]. , 2000, Bulletin du cancer.
[25] G. Noël,et al. [Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853]. , 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[26] R W Veltri,et al. Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. , 1999, Urology.
[27] James Dignam,et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial , 1999, The Lancet.
[28] G. Garas,et al. Intralaboratory variations in the grading of breast carcinoma. , 1982, Archives of pathology & laboratory medicine.
[29] P H Bartels,et al. Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions. , 2000, Cytometry.
[30] M. Silverstein,et al. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. , 1997, Surgical oncology clinics of North America.
[31] C. MacAulay,et al. Nuclear morphometry as an intermediate endpoint biomarker in chemoprevention of cervical carcinoma using alpha-difluoromethylornithine. , 1999, Cytometry.
[32] M. Silverstein,et al. Duct carcinoma in situ: 227 cases without microinvasion. , 1992, European journal of cancer.
[33] R E Hermann,et al. Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ. , 1999, Journal of the American College of Surgeons.
[34] M J Gaffey,et al. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. , 1995, American journal of clinical pathology.
[35] R. Veltri,et al. The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the preoperative prediction of prostate cancer staging and prognosis. , 1998, Seminars in urologic oncology.
[36] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[37] R W Veltri,et al. Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei. , 1996, Urology.
[38] D C Young,et al. An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level. , 1996, The Journal of urology.
[39] A. Patchefsky,et al. Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone , 1992, Cancer.
[40] B Palcic,et al. Malignancy-associated changes in the breast. Changes in chromatin distribution in epithelial cells in normal-appearing tissue adjacent to carcinoma. , 1995, Analytical and quantitative cytology and histology.
[41] A. Sabichi,et al. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. , 1999, Human pathology.
[42] H. Thornton,et al. Ductal carcinoma-in-situ of the breast , 1992, The Lancet.
[43] S. Devries,et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. , 2000, Journal of the National Cancer Institute.
[44] V. Weaver,et al. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. , 1999, Cancer research.
[45] O L Mangasarian,et al. Importance of nuclear morphology in breast cancer prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[46] D. Schultz,et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] D. Visscher,et al. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. , 1990, Archives of pathology & laboratory medicine.
[48] R. Montironi,et al. Computed cell cycle and DNA histogram analyses in image cytometry in breast cancer. , 1993, Journal of clinical pathology.
[49] D. Pinkel,et al. The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.
[50] F. Vicini,et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast‐conserving therapy , 2000, Cancer.
[51] K Rodenacker,et al. Identification of a low‐risk group of stage I breast cancer patients by cytometrically assessed DNA and nuclear texture parameters , 1995, The Journal of pathology.
[52] B Palcic,et al. Nuclear texture measurements in image cytometry. , 1995, Pathologica.
[53] L. Cheng,et al. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. , 1997, Journal of the National Cancer Institute.
[54] W. Dupont,et al. Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy , 1995, Cancer.
[55] J. V. Bacus,et al. Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[56] M. Lagios,et al. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence , 1989, Cancer.